These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12703060)

  • 1. [Molecular mechanisms of insulin secretion].
    Bataille D
    Diabetes Metab; 2002 Dec; 28(6 Suppl):4S7-13. PubMed ID: 12703060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-specific effects of sulfonylureas: lessons from studies of cloned K(ATP) channels.
    Ashcroft FM; Gribble FM
    J Diabetes Complications; 2000; 14(4):192-6. PubMed ID: 11004427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose regulation of insulin secretion independent of the opening or closure of adenosine triphosphate-sensitive K+ channels in beta cells.
    Sato Y; Anello M; Henquin JC
    Endocrinology; 1999 May; 140(5):2252-7. PubMed ID: 10218978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidiabetic sulfonylurea stimulates insulin secretion independently of plasma membrane KATP channels.
    Geng X; Li L; Bottino R; Balamurugan AN; Bertera S; Densmore E; Su A; Chang Y; Trucco M; Drain P
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E293-301. PubMed ID: 17405830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfonylurea sensitivity of adenosine triphosphate-sensitive potassium channels from beta cells and extrapancreatic tissues.
    Gribble FM; Ashcroft FM
    Metabolism; 2000 Oct; 49(10 Suppl 2):3-6. PubMed ID: 11078468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential selectivity of insulin secretagogues: mechanisms, clinical implications, and drug interactions.
    Gribble FM; Reimann F
    J Diabetes Complications; 2003; 17(2 Suppl):11-5. PubMed ID: 12623163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfonylureas enhance exocytosis from pancreatic beta-cells by a mechanism that does not involve direct activation of protein kinase C.
    Tian YA; Johnson G; Ashcroft SJ
    Diabetes; 1998 Nov; 47(11):1722-6. PubMed ID: 9792541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glimepiride block of cloned beta-cell, cardiac and smooth muscle K(ATP) channels.
    Song DK; Ashcroft FM
    Br J Pharmacol; 2001 May; 133(1):193-9. PubMed ID: 11325810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at beta-cells.
    Kramer W; Müller G; Geisen K
    Horm Metab Res; 1996 Sep; 28(9):464-8. PubMed ID: 8911984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic antidiabetic sulfonylureas in vivo: reversible effects on mouse pancreatic beta-cells.
    Remedi MS; Nichols CG
    PLoS Med; 2008 Oct; 5(10):e206. PubMed ID: 18959471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potassium channels of the insulin-secreting B cell.
    Petit P; Loubatières-Mariani MM
    Fundam Clin Pharmacol; 1992; 6(3):123-34. PubMed ID: 1628875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfonylurea receptors, ion channels, and fruit flies.
    Boyd AE
    Diabetes; 1988 Jul; 37(7):847-50. PubMed ID: 2454858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PKC-dependent stimulation of exocytosis by sulfonylureas in pancreatic beta cells.
    Eliasson L; Renström E; Ammälä C; Berggren PO; Bertorello AM; Bokvist K; Chibalin A; Deeney JT; Flatt PR; Gäbel J; Gromada J; Larsson O; Lindström P; Rhodes CJ; Rorsman P
    Science; 1996 Feb; 271(5250):813-5. PubMed ID: 8628999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel enhancer of insulinotrophic action by high glucose (JTT-608) stimulates insulin secretion from pancreatic beta-cells via a new cellular mechanism.
    Itabashi N; Okada K; Muto S; Fujita N; Ohta T; Miyazaki Ji ; Asano Y; Saito T
    J Pharmacol Exp Ther; 2001 Jun; 297(3):953-60. PubMed ID: 11356916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of K+ channels and stimulation of insulin secretion by the sulfonylurea, glimepiride, in relation to its membrane binding in pancreatic islets.
    Schwanstecher M; Mnner K; Panten U
    Pharmacology; 1994 Aug; 49(2):105-11. PubMed ID: 7972319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of action of glyburide on the beta cell.
    Boyd AE; Aguilar-Bryan L; Nelson DA
    Am J Med; 1990 Aug; 89(2A):3S-10S; discussion 51S-53S. PubMed ID: 2117388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misunderstandings and controversies about the insulin-secreting properties of antidiabetic sulfonylureas.
    Henquin JC
    Biochimie; 2017 Dec; 143():3-9. PubMed ID: 28711685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glibenclamide-induced apoptosis is specifically enhanced by expression of the sulfonylurea receptor isoform SUR1 but not by expression of SUR2B or the mutant SUR1(M1289T).
    Hambrock A; de Oliveira Franz CB; Hiller S; Osswald H
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1031-7. PubMed ID: 16306272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfonylurea and non-sulfonylurea hypoglycemic agents: pharmachological properties and tissue selectivity.
    Nagashima K; Takahashi A; Ikeda H; Hamasaki A; Kuwamura N; Yamada Y; Seino Y
    Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S75-8. PubMed ID: 15563985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of ATP-sensitive K+ channels by taurine through a benzamido-binding site on sulfonylurea receptor 1.
    Park EJ; Bae JH; Kim SY; Lim JG; Baek WK; Kwon TK; Suh SI; Park JW; Lee IK; Ashcroft FM; Song DK
    Biochem Pharmacol; 2004 Mar; 67(6):1089-96. PubMed ID: 15006545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.